Find an Eye MD near you!

The companies will jointly develop a combination of the angiopoietin2 antibody nesvacumab and the anti-VEGF aflibercept for the treatment of wet AMD and diabetic macular edema.

Read full article on AAO News


Diagnose This: Minimizing ocular movement during phacoemulsification

◦Attention colleagues! Please reach out to your member of Congress regarding the rising drug prices and lack of tra…

Looks like a great weekend for the WVAEPS 2018 Scientific Conference at the Greenbrier!!! Hope you made your regis…

Suffering eye strain at work? Follow these tips from the American Academy of Ophthalmology to get some relief.